Patent Grant
11878135
The present disclosure relates generally to the delivery of treatment materials to a wound. The present disclosure relates more particularly to the delivery of treatment materials into a tunneling wound.
Tunneling wounds are secondary wounds leading off from a primary wound. Tunneling wounds typically take the form of channels that extend from the primary wound deeper into the tissue. The channels may be of an irregular shape and may split off into additional tunneling wounds. A conventional treatment for a tunneling wound includes packing the wound with absorbent materials along with an antimicrobial treatment to absorb wound exudate and medicate the wound to promote healing.
An alternative to conventional tunneling wound treatments includes using bioresorbable products, which do not need to be removed from the wound after insertion. These bioresorbable products create a healing environment within the wound. However, these products may be challenging to apply as their structure tends to rapidly break down (e.g., gel, etc.) when hydrated. Hydration may result from exposure of the products to excess moisture and/or by wound exudate before and during the delivery process. Devices and methods are desired that improve the delivery of treatment materials for tunneling wounds.
One implementation of the present disclosure is a medical delivery device for treating a tunneling wound. The device includes an outer sleeve and a plunger configured to be received within a cavity of the outer sleeve. The plunger includes a shaft and a head that together define an opening extending through a central axis of the plunger. The device additionally includes a hollow tube extending through the opening and configured to deliver a fluid to a wound treatment material contained within the cavity.
In some embodiments, the outer sleeve may further include a flap disposed on an end of the outer sleeve. The flap may be reconfigurable between a closed position, in which the flap is configured to shield a cavity opening, and an open position, in which the flap is configured to allow the wound treatment material to be ejected from the cavity through the cavity opening and into the tunneling wound. In some embodiments, the flap may be configured to open upon application of a predetermined force to the flap.
In some embodiments, both the outer sleeve and the head of the plunger have a rectangular cross section normal to their central axis. In some embodiments, the wound treatment material is a freeze dried collagen material. In some embodiments, the freeze dried collagen material is provided in a rope form and includes a central axis opening configured to receive the hollow tube.
In any of the above embodiments, the hollow tube may additionally include a plurality of perforations disposed proximate to an end of the hollow tube and configured to deliver a fluid from the hollow tube to the wound treatment material along a length of the wound treatment material. The hollow tube may be configured to deliver the fluid after the wound treatment material is deposited in the tunneling wound. In some embodiments, the wound treatment material contains an active component configured to interface with the fluid delivered to the wound treatment material.
Another implementation is a method of deploying a wound treatment material into a tunneling wound. The method includes preparing a medical delivery device including an outer sleeve and a plunger. The outer sleeve defines a cavity that is configured to receive both the wound treatment material and the plunger. The method additionally includes depressing the plunger to deliver the wound treatment material from the cavity and into the tunneling wound, delivering a fluid to the wound treatment material by passing a fluid through a hollow tube passing through the plunger and inserted into the wound treatment material, and retracting the hollow tube from the wound treatment material. In some embodiments, the method may additionally include passing a head of the plunger through the cavity and past an end of the cavity, and rotating the plunger to prevent the plunger from being able to retract through the outer sleeve.
In some embodiments, the method may additionally include compressing the wound treatment material and inserting the wound treatment material into the cavity.
Another implementation is a kit for a medical delivery device used to deploy a wound treatment material into a tunneling wound. The kit includes an outer sleeve defining a cavity and a plunger configured to be received within the cavity. The plunger includes a shaft including a first shaft end and a second shaft end, a head disposed on the first shaft end, and an opening extending through a central axis of the shaft and the head. The kit includes a hollow tube that extends through the opening and one or more freeze dried collagen materials configured to fit within the cavity and around the hollow tube.
In some embodiments, a length of the hollow tube may be greater than a combined length of the plunger and 50% of the freeze dried collagen material.
Those skilled in the art will appreciate that the summary is illustrative only and is not intended to be in any way limiting. Other aspects, inventive features, and advantages of the devices and/or processes described herein, as defined solely by the claims, will become apparent in the detailed description set forth herein and taken in conjunction with the accompanying drawings.
Overview
Referring generally to the FIGURES, a medical delivery device configured for use with treating tunneling wounds is provided, according to various exemplary embodiments. The device is configured to deliver a wound treatment material to a tunneling wound and to minimize exposure of the wound treatment material to exudate from surrounding wounds, entry wounds from which the tunneling wound extends, and/or an entry region of the tunneling wound. The device is configured to eject the wound treatment material from a protective sleeve or outer sleeve, through an opening in the sleeve, and directly into the tunneling wound. The device includes a plunger configured to facilitate delivery of the wound treatment material into the tunneling wound (e.g., the insertion depth of the wound treatment material into the tunneling wound, the speed of delivery, etc.). The device also includes an applicator or hollow tube configured to deliver a fluid to the wound treatment material once inserted into the tunneling wound. Among various alternatives, the fluid may be a hydrating solution or a medicant (e.g., an antimicrobial solution to promote healing, etc.).
A method for delivery of the wound treatment material includes preparing the medical delivery device for use with inserting the wound treatment material into the tunneling wound, depressing the plunger to eject the wound treatment material from a cavity defined by the protective sleeve, delivering the fluid to the wound treatment material by passing the fluid through the hollow tube, and retracting the hollow tube from the wound treatment material. The protective sleeve and the plunger for the medical delivery device may be shaped to facilitate the removal of the hollow tube from the wound treatment material without repositioning the wound treatment material. For example, a head of the plunger and an opening defined by the protective sleeve may be substantially rectangular. A method of ejecting the wound treatment material from the cavity may include depressing the plunger such that the head of the plunger passes through the opening in the sleeve and rotating the plunger by approximately 45° such that the head is prevented from being retracted back into the cavity.
The device may be provided as part of a kit including a freeze dried collagen material. The freeze dried collagen material may be configured to fit within the cavity and around the hollow tube such that any fluids passing through the hollow tube are received along an inner portion (e.g., a central portion) of the freeze dried collagen material rather than directly upon the tunneling wound. These and other features and advantages of the medical delivery device are described in detail below.
Medical Delivery Device Construction
Referring now to
As shown in
In the embodiment of
As shown in
Outer Sleeve
An exemplary embodiment of an outer sleeve 200 for the delivery device 100 is shown in
As shown in
The outer sleeve 200 additionally defines an opening at each end of the inner cavity 202, shown as first cavity opening 204 and second cavity opening 220. Each of the first cavity opening 204 and the second cavity opening 220 have substantially the same cross-sectional shape as the inner cavity 202 (e.g., a square). In the embodiment of
The outer sleeve 200 may additionally include one or more flaps 208 disposed on an end of the outer sleeve 200. In the embodiment of
Each one of the flaps 208 is reconfigurable between an open position, in which the flap 208 is configured to allow the wound treatment material 300 to be ejected from the inner cavity 202 through the first cavity opening 204, and a closed position, in which the flap 208 is configured to shield the first cavity opening 204. In the embodiment of
The flaps 208 are configured to move from the closed position to the open position upon application of a predetermined force to the flaps 208. To secure the flaps 208 over the first cavity opening 204 in the closed position, the flaps 208 may be folded over one another, interlocked with one another, or configured to removably engage with the outer sleeve 200. In an exemplary embodiment, one or more flaps 208 may include a slot that is configured to engage with another flap 208 in the closed position. In other embodiments, the outer sleeve 200 may include features (e.g., slots, clips, etc.) configured to receive one or more flaps 208 in the closed position. In yet other embodiments, one or more flaps 208 may be removably coupled to one another using an adhesive product in the closed position.
Plunger
A plunger 400 for the medical delivery device 100 is shown in
As shown in
The plunger 400 includes an opening 406 extending along a full length of the plunger 400 parallel to its central axis 408. In the embodiment of
The shaft 402 of the plunger 400 extends through the second cavity opening 220 of the outer sleeve 200. The shaft 402 may be manipulated by a user to reposition the plunger 400 with respect to the outer sleeve 200. A length of the shaft 402, in a direction substantially parallel to the central axis of the plunger 400, is greater than a combined length of the outer sleeve and the head 404 of the plunger 400 (i.e., the length of the shaft 402 is sufficient to allow the user to push the head 404 of the plunger 400 through an entire length of the inner cavity 202 and beyond the first cavity opening 204).
The shaft 402 may be configured in a variety of different shapes. For example, the shaft 402 may be cylindrical, triangular, etc. In the embodiment of
Hollow Tube
A hollow tube 500 for the medical delivery device 100 is shown in
The hollow tube 500 is configured to deliver a fluid through the device 100 and into the wound treatment material 300. The fluid may be one or a combination of a hydrating solution to wet an interior portion of the wound treatment material 300 (e.g., to facilitate gelling of the wound treatment material 300 onto the surfaces of the tunneling wound) and a medicant such as an antimicrobial solution. In an exemplary embodiment, the hollow tube 500 is configured to provide a wound irrigation solution such as Prontasan to the wound treatment material 300. In another embodiment, the hollow tube 500 is configured to provide a solution configured to interact and/or react with one or more active components in the wound treatment material 300 (e.g., the solution could contain glucose, which could interact with glucose oxidase in the wound treatment material 300 to generate hydrogen peroxide, etc.).
As shown in
Wound Treatment Material
A wound treatment material 300 configured for delivery by the medical delivery device 100 is shown in
Similar to the outer sleeve 200 and the head 404 of the plunger 400, the wound treatment material 300 is configured in the shape of a rectangular cuboid having uniform cross-section along its length. A cross-sectional geometry of the wound treatment material 300, normal to a central axis for the wound treatment material 300, is approximately the same as the cross-sectional geometry of the inner cavity 202 and the head 404 of the plunger 400. In the embodiment of
As shown in
The central axis opening 302 extends throughout the length of the wound treatment material 300 and provides access to an inner portion and/or a central portion of the wound treatment material 300. The central axis opening 302 may be configured in a variety of different shapes. In the embodiment of
In an exemplary embodiment, the wound treatment material 300 is composed of a freeze dried collagen material (i.e., an oxidized regenerated cellulose/collagen (ORC) or collagen/ORC/silver-ORC) such as Promogran or Prisma. The wound treatment material 300 may additionally contain active components such as antimicrobials, antioxidants, and/or anti-inflammatories to enhance the healing benefits of the material 300. The wound treatment material 300 may alternatively or additionally contain active components that are configured to interact with and/or react with a fluid delivered by the hollow tube 500 to wound treatment material 300. For example, the wound treatment material 300 may contain glucose oxidase, which interacts with glucose to generate hydrogen peroxide.
Delivery of Wound Treatment Material
A method of deploying a wound treatment material 300 into a tunneling wound 20 is illustrated in
As shown in
In various alternative embodiments, the method of preparing the device 100 may further include compressing the wound treatment material 300 and inserting the wound treatment material 300 into the inner cavity 202 of the outer sleeve 200.
The method of deploying the wound treatment material 300 includes depressing the plunger 400 to deliver the wound treatment material 300 from the inner cavity 202 and into the tunneling wound 20. As shown in
The operation of depressing the plunger 400 continues until the wound treatment material 300 is completely inserted into the tunneling wound 20. As shown in
The method of deployment further includes delivering a fluid to the wound treatment material 300 by passing the fluid through the hollow tube 500. This operation allows fluid to be introduced into an inner portion of the wound treatment material 300. The fluid may provide a form of hydration to the wound treatment material 300 or serve as a medicant (e.g., an antimicrobial solution such as Prontasan) to promote healing of the tunneling wound 20.
The method of deployment additionally includes retracting the hollow tube 500 from the wound treatment material 300. A method for retracting the hollow tube 500 from the wound treatment material 300 as illustrated in
In the embodiment of
As shown in
Configuration of Exemplary Embodiments
The construction and arrangement of the systems and methods as shown in the various exemplary embodiments are illustrative only. Although only a few embodiments have been described in detail in this disclosure, many modifications are possible (e.g., variations in sizes, dimensions, structures, shapes and proportions of the various elements, values of parameters, mounting arrangements, use of materials, colors, orientations, etc.). For example, the position of elements can be reversed or otherwise varied and the nature or number of discrete elements or positions can be altered or varied. Accordingly, all such modifications are intended to be included within the scope of the present disclosure. The order or sequence of any process or method steps can be varied or re-sequenced according to alternative embodiments. Other substitutions, modifications, changes, and omissions can be made in the design, operating conditions and arrangement of the exemplary embodiments without departing from the scope of the present disclosure.
This Application claims the benefit of priority to international patent application number PCT/IB2019/057159, filed on Aug. 26, 2019, which claims the benefit of priority to U.S. Provisional Application No. 62/723,245, filed on Aug. 27, 2018, the complete disclosures of which are hereby incorporated herein by reference in their entireties.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/IB2019/057159 | 8/26/2019 | WO |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2020/044205 | 3/5/2020 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 1355846 | Rannells | Oct 1920 | A |
| 2547758 | Keeling | Apr 1951 | A |
| 2632443 | Lesher | Mar 1953 | A |
| 2682873 | Evans et al. | Jul 1954 | A |
| 2910763 | Lauterbach | Nov 1959 | A |
| 2969057 | Simmons | Jan 1961 | A |
| 3066672 | Crosby, Jr. et al. | Dec 1962 | A |
| 3367332 | Groves | Feb 1968 | A |
| 3520300 | Flower, Jr. | Jul 1970 | A |
| 3568675 | Harvey | Mar 1971 | A |
| 3648692 | Wheeler | Mar 1972 | A |
| 3682180 | McFarlane | Aug 1972 | A |
| 3826254 | Mellor | Jul 1974 | A |
| 4080970 | Miller | Mar 1978 | A |
| 4096853 | Weigand | Jun 1978 | A |
| 4139004 | Gonzalez, Jr. | Feb 1979 | A |
| 4165748 | Johnson | Aug 1979 | A |
| 4184510 | Murry et al. | Jan 1980 | A |
| 4233969 | Lock et al. | Nov 1980 | A |
| 4245630 | Lloyd et al. | Jan 1981 | A |
| 4256109 | Nichols | Mar 1981 | A |
| 4261363 | Russo | Apr 1981 | A |
| 4275721 | Olson | Jun 1981 | A |
| 4284079 | Adair | Aug 1981 | A |
| 4297995 | Golub | Nov 1981 | A |
| 4333468 | Geist | Jun 1982 | A |
| 4373519 | Errede et al. | Feb 1983 | A |
| 4382441 | Svedman | May 1983 | A |
| 4392853 | Muto | Jul 1983 | A |
| 4392858 | George et al. | Jul 1983 | A |
| 4419097 | Rowland | Dec 1983 | A |
| 4465485 | Kashmer et al. | Aug 1984 | A |
| 4475909 | Eisenberg | Oct 1984 | A |
| 4480638 | Schmid | Nov 1984 | A |
| 4525166 | Leclerc | Jun 1985 | A |
| 4525374 | Vaillancourt | Jun 1985 | A |
| 4540412 | Van Overloop | Sep 1985 | A |
| 4543100 | Brodsky | Sep 1985 | A |
| 4548202 | Duncan | Oct 1985 | A |
| 4551139 | Plaas et al. | Nov 1985 | A |
| 4569348 | Hasslinger | Feb 1986 | A |
| 4605399 | Weston et al. | Aug 1986 | A |
| 4608041 | Nielsen | Aug 1986 | A |
| 4640688 | Hauser | Feb 1987 | A |
| 4655754 | Richmond et al. | Apr 1987 | A |
| 4664662 | Webster | May 1987 | A |
| 4710165 | McNeil et al. | Dec 1987 | A |
| 4733659 | Edenbaum et al. | Mar 1988 | A |
| 4743232 | Kruger | May 1988 | A |
| 4758220 | Sundblom et al. | Jul 1988 | A |
| 4787888 | Fox | Nov 1988 | A |
| 4826494 | Richmond et al. | May 1989 | A |
| 4838883 | Matsuura | Jun 1989 | A |
| 4840187 | Brazier | Jun 1989 | A |
| 4863449 | Therriault et al. | Sep 1989 | A |
| 4872450 | Austad | Oct 1989 | A |
| 4878901 | Sachse | Nov 1989 | A |
| 4897081 | Poirier et al. | Jan 1990 | A |
| 4906233 | Moriuchi et al. | Mar 1990 | A |
| 4906240 | Reed et al. | Mar 1990 | A |
| 4919654 | Kalt | Apr 1990 | A |
| 4941882 | Ward et al. | Jul 1990 | A |
| 4953565 | Tachibana et al. | Sep 1990 | A |
| 4969880 | Zamierowski | Nov 1990 | A |
| 4985019 | Michelson | Jan 1991 | A |
| 5037397 | Kalt et al. | Aug 1991 | A |
| 5086170 | Luheshi et al. | Feb 1992 | A |
| 5092858 | Benson et al. | Mar 1992 | A |
| 5100396 | Zamierowski | Mar 1992 | A |
| 5134994 | Say | Aug 1992 | A |
| 5149331 | Ferdman et al. | Sep 1992 | A |
| 5167613 | Karami et al. | Dec 1992 | A |
| 5176663 | Svedman et al. | Jan 1993 | A |
| 5215522 | Page et al. | Jun 1993 | A |
| 5232453 | Plass et al. | Aug 1993 | A |
| 5261893 | Zamierowski | Nov 1993 | A |
| 5278100 | Doan et al. | Jan 1994 | A |
| 5279550 | Habib et al. | Jan 1994 | A |
| 5298015 | Komatsuzaki et al. | Mar 1994 | A |
| 5342376 | Ruff | Aug 1994 | A |
| 5344415 | DeBusk et al. | Sep 1994 | A |
| 5358494 | Svedman | Oct 1994 | A |
| 5437622 | Carion | Aug 1995 | A |
| 5437651 | Todd et al. | Aug 1995 | A |
| 5527293 | Zamierowski | Jun 1996 | A |
| 5549584 | Gross | Aug 1996 | A |
| 5556375 | Ewall | Sep 1996 | A |
| 5607388 | Ewall | Mar 1997 | A |
| 5636643 | Argenta et al. | Jun 1997 | A |
| 5645081 | Argenta et al. | Jul 1997 | A |
| 6071267 | Zamierowski | Jun 2000 | A |
| 6135116 | Vogel et al. | Oct 2000 | A |
| 6241747 | Ruff | Jun 2001 | B1 |
| 6287316 | Agarwal et al. | Sep 2001 | B1 |
| 6309454 | Harvey et al. | Oct 2001 | B1 |
| 6345623 | Heaton et al. | Feb 2002 | B1 |
| 6488643 | Tumey et al. | Dec 2002 | B1 |
| 6493568 | Bell et al. | Dec 2002 | B1 |
| 6553998 | Heaton et al. | Apr 2003 | B2 |
| 6814079 | Heaton et al. | Nov 2004 | B2 |
| 8461410 | Cullen et al. | Jun 2013 | B2 |
| 20010056254 | Cragg | Dec 2001 | A1 |
| 20020077661 | Saadat | Jun 2002 | A1 |
| 20020115951 | Norstrem et al. | Aug 2002 | A1 |
| 20020120185 | Johnson | Aug 2002 | A1 |
| 20020143286 | Tumey | Oct 2002 | A1 |
| 20130237898 | Kirkham et al. | Sep 2013 | A1 |
| 20140046239 | Taniguchi et al. | Feb 2014 | A1 |
| 20150351974 | Levantino et al. | Dec 2015 | A1 |
| 20180250172 | Turner | Sep 2018 | A1 |
| Number | Date | Country |
|---|---|---|
| 550575 | Mar 1986 | AU |
| 745271 | Mar 2002 | AU |
| 755496 | Dec 2002 | AU |
| 2005436 | Jun 1990 | CA |
| 26 40 413 | Mar 1978 | DE |
| 43 06 478 | Sep 1994 | DE |
| 29 504 378 | Sep 1995 | DE |
| 0100148 | Feb 1984 | EP |
| 0117632 | Sep 1984 | EP |
| 0161865 | Nov 1985 | EP |
| 0358302 | Mar 1990 | EP |
| 1018967 | Jul 2000 | EP |
| 692578 | Jun 1953 | GB |
| 2 195 255 | Apr 1988 | GB |
| 2 197 789 | Jun 1988 | GB |
| 2 220 357 | Jan 1990 | GB |
| 2 235 877 | Mar 1991 | GB |
| 2 329 127 | Mar 1999 | GB |
| 2 333 965 | Aug 1999 | GB |
| 4129536 | Aug 2008 | JP |
| 71559 | Apr 2002 | SG |
| 8002182 | Oct 1980 | WO |
| 8704626 | Aug 1987 | WO |
| 90010424 | Sep 1990 | WO |
| 93009727 | May 1993 | WO |
| 94020041 | Sep 1994 | WO |
| 9605873 | Feb 1996 | WO |
| 9718007 | May 1997 | WO |
| 9913793 | Mar 1999 | WO |
| WO-2005123170 | Dec 2005 | WO |
| Entry |
|---|
| International Search Report & Written Opinion in International Application No. PCT/IB2019/057159, dated Jan. 8, 2020. |
| Louis C. Argenta, MD and Michael J. Morykwas, PHD; Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Clinical Experience; Annals of Plastic Surgery; vol. 38, No. 6, Jun. 1997; pp. 563-576. |
| Susan Mendez-Eatmen, RN; “When wounds Won't Heal” RN Jan. 1998, vol. 61 (1); Medical Economics Company, Inc., Montvale, NJ, USA; pp. 20-24. |
| James H. Blackburn II, MD et al.: Negative-Pressure Dressings as a Bolster for Skin Grafts; Annals of Plastic Surgery, vol. 40, No. 5, May 1998, pp. 453-457; Lippincott Williams & Wilkins, Inc., Philidelphia, PA, USA. |
| John Masters; “Reliable, Inexpensive and Simple Suction Dressings”; Letter to the Editor, British Journal of Plastic Surgery, 1998, vol. 51 (3), p. 267; Elsevier Science/The British Association of Plastic Surgeons, UK. |
| S.E. Greer, et al. “The Use of Subatmospheric Pressure Dressing Therapy to Close Lymphocutaneous Fistulas of the Groin” British Journal of Plastic Surgery (2000), 53, pp. 484-487. |
| George V. Letsou, MD., et al; “Stimulation of Adenylate Cyclase Activity in Cultured Endothelial Cells Subjected to Cyclic Stretch”; Journal of Cardiovascular Surgery, 31, 1990, pp. 634-639. |
| Orringer, Jay, et al; “Management of Wounds in Patients with Complex Enterocutaneous Fistulas”; Surgery, Gynecology & Obstetrics, Jul. 1987, vol. 165, pp. 79-80. |
| International Search Report for PCT International Application PCT/GB95/01983; dated Nov. 23, 1995. |
| PCT International Search Report for PCT International Application PCT/GB98/02713; dated Jan. 8, 1999. |
| PCT Written Opinion; PCT International Application PCT/GB98/02713; dated Jun. 8, 1999. |
| PCT International Examination and Search Report, PCT International Application PCT/GB96/02802; dated Jan. 15, 1998 & Apr. 29, 1997. |
| PCT Written Opinion, PCT International Application PCT/GB96/02802; dated Sep. 3, 1997. |
| Dattilo, Philip P., Jr., et al; “Medical Textiles: Application of an Absorbable Barbed Bi-directional Surgical Suture”; Journal of Textile and Apparel, Technology and Management, vol. 2, Issue 2, Spring 2002, pp. 1-5. |
| Kostyuchenok, B.M., et al; “Vacuum Treatment in the Surgical Management of Purulent Wounds”; Vestnik Khirurgi, Sep. 1986, pp. 18-21 and 6 page English translation thereof. |
| Davydov, Yu. A., et al; “Vacuum Therapy in the Treatment of Purulent Lactation Mastitis”; Vestnik Khirurgi, May 14, 1986, pp. 66-70, and 9 page English translation thereof. |
| Yusupov. Yu.N., et al; “Active Wound Drainage”, Vestnki Khirurgi, vol. 138, Issue 4, 1987, and 7 page English translation thereof. |
| Davydov, Yu.A., et al; “Bacteriological and Cytological Assessment of Vacuum Therapy for Purulent Wounds”; Vestnik Khirugi, Oct. 1988, pp. 48-52, and 8 page English translation thereof. |
| Davydov, Yu.A., et al; “Concepts for the Clinical-Biological Management of the Wound Process in the Treatment of Purulent Wounds by Means of Vacuum Therapy”; Vestnik Khirurgi, Jul. 7, 1980, pp. 132-136, and 8 page English translation thereof. |
| Chariker, Mark E., M.D., et al.; “Effective Management of incisional and cutaneous fistulae with closed suction wound drainage”; Contemporary Surgery, vol. 34, Jun. 1989, pp. 59-63. |
| Egnell Minor, Instruction Book, First Edition, 300 7502, Feb. 1975, pp. 24. |
| Egnell Minor: Addition to the Users Manual Concerning Overflow Protection—Concerns all Egnell Pumps, Feb. 3, 1983, pp. 2. |
| Svedman, P.: “Irrigation Treatment of Leg Ulcers”, The Lancet, Sep. 3, 1983, pp. 532-534. |
| Chinn, Steven D. et al.: “Closed Wound Suction Drainage”, The Journal of Foot Surgery, vol. 24, No. 1, 1985, pp. 76-81. |
| Arnljots, Björn et al.: “Irrigation Treatment in Split-Thickness Skin Grafting of Intractable Leg Ulcers”, Scand J. Plast Reconstr. Surg., No. 19, 1985, pp. 211-213. |
| Svedman, P.: “A Dressing Allowing Continuous Treatment of a Biosurface”, IRCS Medical Science: Biomedical Technology, Clinical Medicine, Surgery and Transplantation, vol. 7, 1979, p. 221. |
| Svedman, P. et al: “A Dressing System Providing Fluid Supply and Suction Drainage Used for Continuous of Intermittent Irrigation”, Annals of Plastic Surgery, vol. 17, No. 2, Aug. 1986, pp. 125-133. |
| N.A. Bagautdinov, “Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of Soft Tissues,” Current Problems in Modern Clinical Surgery: Interdepartmental Collection, edited by V. Ye Volkov et al. (Chuvashia State University, Cheboksary, U.S.S.R. 1986); pp. 94-96 (copy and certified translation). |
| K.F. Jeter, T.E. Tintle, and M. Chariker, “Managing Draining Wounds and Fistulae: New and Established Methods,” Chronic Wound Care, edited by D. Krasner (Health Management Publications, Inc., King of Prussia, PA 1990), pp. 240-246. |
| G. {hacek over (Z)}ivadinovi?, V. ?uki?, {hacek over (Z)}. Maksimovi?, ?. Radak, and P. Pe{hacek over (s)}ka, “Vacuum Therapy in the Treatment of Peripheral Blood Vessels,” Timok Medical Journal 11 (1986), pp. 161-164 (copy and certified translation). |
| F.E. Johnson, “An Improved Technique for Skin Graft Placement Using a Suction Drain,” Surgery, Gynecology, and Obstetrics 159 (1984), pp. 584-585. |
| A.A. Safronov, Dissertation Abstract, Vacuum Therapy of Trophic Ulcers of the Lower Leg with Simultaneous Autoplasty of the Skin (Central Scientific Research Institute of Traumatology and Orthopedics, Moscow, U.S.S.R. 1967) (copy and certified translation). |
| M. Schein, R. Saadia, J.R. Jamieson, and G.A.G. Decker, “The ‘Sandwich Technique’ in the Management of the Open Abdomen,” British Journal of Surgery 73 (1986), pp. 369-370. |
| D.E. Tribble, An Improved Sump Drain-Irrigation Device of Simple Construction, Archives of Surgery 105 (1972) pp. 511-513. |
| M.J. Morykwas, L.C. Argenta, E.I. Shelton-Brown, and W. McGuirt, “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Animal Studies and Basic Foundation,” Annals of Plastic Surgery 38 (1997), pp. 553-562 (Morykwas I). |
| C.E. Tennants, “The Use of Hypermia in the Postoperative Treatment of Lesions of the Extremities and Thorax,” Journal of the American Medical Association 64 (1915), pp. 1548-1549. |
| Selections from W. Meyer and V. Schmieden, Bier's Hyperemic Treatment in Surgery, Medicine, and the Specialties: A Manual of Its Practical Application, (W.B. Saunders Co., Philadelphia, PA 1909), pp. 17-25, 44-64, 90-96, 167-170, and 210-211. |
| V.A. Solovev et al., Guidelines, The Method of Treatment of Immature External Fistulas in the Upper Gastrointestinal Tract, editor-in-chief Prov. V.I. Parahonyak (S.M. Kirov Gorky State Medical Institute, Gorky, U.S.S.R. 1987) (“Solovev Guidelines”). |
| V.A. Kuznetsov & N.a. Bagautdinov, “Vacuum and Vacuum-Sorption Treatment of Open Septic Wounds,” in II All-Union Conference on Wounds and Wound Infections: Presentation Abstracts, edited by B.M. Kostyuchenok et al. (Moscow, U.S.S.R. Oct. 28-29, 1986) pp. 91-92 (“Bagautdinov II”). |
| V.A. Solovev, Dissertation Abstract, Treatment and Prevention of Suture Failures after Gastric Resection (S.M. Kirov Gorky State Medical Institute, Gorky, U.S.S.R. 1988) (“Solovev Abstract”). |
| V.A.C.® Therapy Clinical Guidelines: A Reference Source for Clinicians; Jul. 2007. |
| Number | Date | Country | |
|---|---|---|---|
| 20210187259 A1 | Jun 2021 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62723245 | Aug 2018 | US |
